Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-02, Stock:ABBV, The news for the past five days is as follows:
2021-05-25: NEWS1: AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology.NEWS2: AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.NEWS3: 2 High-Yield Dividend Stocks for 2021.NEWS4: 3 Strong Stocks for Your Income Tax Return.
2021-05-26: NEWS1: AbbVie: The Market Can't See Beyond Humira.NEWS2: AbbVie's (ABBV) Venclyxto Gets EU Nod for First-Line AML.NEWS3: AbbVie to Present at Bernstein's 37th Annual Strategic Decisions Conference.NEWS4: AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society (AHS) Annual Scientific Meeting.NEWS5: 5 Reasons Not to Sell During a Market Crash.
2021-05-27: NEWS1: 2 Stocks to Buy With Dividends Yielding More Than 3%.NEWS2: AbbVie Stock Is Tackling Its New Buy Point — Is It A Buy Right Now?.NEWS3: 5 Stocks Warren Buffett Is Selling That You Should Be Buying.
2021-05-28: nan
2021-06-01: nan

Answer: Decrease